*Refresh the page if the below document does not appear.
Baxter to establish Global Pharmaceutical R&D center in Ahmedabad
Baxter pharmaceuticals India announced the innaugration of state-of-the-art R&D centre in Ahmedabad, Gujarat. The area of the facility is 20,500-square-foot and it will be able to propel the innovation in the generic and differentiated injectable pharmaceuticals space.
Alembic Pharma receives form 483 with 4 observations from USFDA
The firm informed in a regulatory filing that USFDA had conducted an inspection at the company’s Panelav oncology injectable formulation facility in Gujarat from 4th to 14th October, 2022 and has issued a Form 483 with four procedural observations after the inspection.
ED brings Chandigarh-based pharma firm's ₹185 crore worth of assets under PMLA
Enforcement Directorate stated that after the provisional order was issued under the PMLA (Prevention of Money Laundering Act), it has attached assets worth more than ₹185 crore of Chandigarh-based Surya Pharmaceuticals, in connection with a case of alleged bank loan fraud.
J&J beats third quarter sales estimates backed by strong demand of pharmaceuticals
Johnson & Johnson announced the jump of their sales over the estimates given by the analysts’ for third-quarter sales. It became possible because of the two most in-demand drugs namely Cancer drug Darzalex and Crohn’s disease drug Stelara.
All company board directors liable for production of substandard drugs
The board of directors of Sunrise International Labs filed a petition to the Madras High Court to exempt them from any proceedings as they were not involved in the day-to-day working of the company to which the High Court responded by saying that all directors are liable in the present case.
India going beyond health insurance, ensuring health assurance: PM Modi
On 17th October, PM Narendra Modi kickstarted the distribution of PMJAY-MA Yojna Ayushman cards in Gujarat with the help of video conferencing and mentioned that India is going beyond health insurance to ensure health assurance. Additionally, he also mentioned that this program aims for health for all.
Romania-based Pharma group Terapia takes over Uractiv brand
Romanian Pharma group Terapia, Part of Sun
Pharma group has decided to take over the
Uractiv brand from local companies Fiterman
Pharma. The assets brought by Terapia mainly
comprises of food supplements products used
for urological care and maintaining the health
of the urinary tract.
